Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06496659 · ClinicalTrials.gov registry record · NA

Segmentectomy After Induction Therapy (SAINT)

A NA study of Segmentectomy, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06496659 is a NA study of Segmentectomy that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06496659, a NA study of Segmentectomy, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The primary objective will be to determine the feasibility of performing a high-quality sublobar anatomic resection (segmentectomy) with R0 margin status on final pathology for patients who received induction therapy for NSCLC and are downstaged to ≤ycT1cN0M0 (TDi 3cm or less). T1c is tumor staging 1 and c stands for tumor is considered larger than 2cm but no larger than 3cm across; N0 is No regional lymph node metastasis; M0 is No distant metastasis.

Conditions Studied

Interventions

  • PROCEDURE Segmentectomy

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-08-02
Est. Completion 2029-07-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT06496659

The ClinicalTrials.gov registry entry for NCT06496659 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Segmentectomy appearing as the primary indexed condition, and to 1 intervention - of which Segmentectomy is the first listed.

NCT06496659 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06496659 about?

NCT06496659 is a clinical study titled "Segmentectomy After Induction Therapy (SAINT)". The primary objective will be to determine the feasibility of performing a high-quality sublobar anatomic resection (segmentectomy) with R0 margin status on final pathology for patients who received induction therapy for NSCLC and are downstaged to ≤ycT1cN0M0 (TDi 3cm or less). T1c is tumor staging ...

What is the current status of trial NCT06496659?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-08-02. Estimated completion is 2029-07-30.

What conditions does trial NCT06496659 study?

This clinical trial studies the following conditions: Segmentectomy.

What interventions are being tested in trial NCT06496659?

The interventions under investigation include: Segmentectomy (PROCEDURE).

Who is sponsoring clinical trial NCT06496659?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06496659 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Segmentectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.